Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Shinagawa-Ku
Clinical trial register · Japan

Clinical Trials in Shinagawa-Ku, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2517 matching records held by the registry are in this view. Synced 15 Nov 2026, 03:19 UTC
2517
Studies in scope
all four open statuses
1288
Recruiting now
open to new participants
355
Lead sponsors
across recruiting studies
Top sites
Fukuoka 558 Nagoya 513 Sapporo 400 Tokyo 375 Osaka 354

Trials with a site in Shinagawa-Ku

19 of 2517 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
Daiichi Sankyo
Phase 1/2
220
Kashiwa, Isehara, Yokohama, Hirakata, Chuo-ku, Koto-ku, Shinagawa-ku, Fukuoka
2026-09-17
Not yet open
Bloomage Biotechnology Corp., Ltd.
Not applicable
90
Nerima-ku, Shinagawa-ku
2026-09-09
Recruiting
Takeda
Phase 3
300
Nagoya, Fukushima, Gifu, Fukuyama-shi, Amagasaki-shi, Mibu, Bunkyo-ku, Shinagawa-ku
2026-05-21
Recruiting
Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study)
NCT07347197Heart Failure, Ischemic Heart Failure, Ischemic Heart Disease, Dilated Cardiomyopathy (DCM)
Heartseed Inc.
Phase 1/2
14
Tsukuba, Kawasaki, Matsumoto, Shinagawa-Ku, Shinjuku-ku
2026-01-19
Recruiting
Indena S.p.A
Not applicable
76
Nerima-ku, Shinagawa-Ku
2025-12-08
Recruiting
Eli Lilly and Company
Phase 2
222
Shinagawa-ku, Shinjuku, Tokyo
2025-11-03
Recruiting
AstraZeneca
Phase 1
72
Shinagawa-ku, Yoshida-gun
2025-11-03
Recruiting
Novartis Pharmaceuticals
Phase 2
224
Nagoya, Matsudo, Kawasaki, Yokohama, Habikino, Shinagawa Ku, Fukuoka, Kyoto
2025-05-16
Active, closed
mAbxience Research S.L.
Phase 3
726
Hakodate-shi, Okayama, Shinagawa-Ku, Shizuoka
2024-12-30
Active, closed
Orthomedico Inc.
Not applicable
24
Nerima-ku, Shinagawa-ku
2024-12-02
Active, closed
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
NCT06157892Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms, HER2 Positive Breast Neoplasms
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
54
Koto-ku, Shinagawa-ku, Okayama, Tokyo
2024-05-20
Active, closed
Comparative Efficacy, Safety, PK, and Immunogenicity Study
NCT05853354Osteoporosis, Postmenopausal
Luye Pharma Group Ltd.
Phase 3
392
Gifu, Chikugo, Miyako-gun, Yame-gun, Matsumoto-shi, Fujimi, Fukuroi, Shinagawa-ku
2023-04-05
Active, closed
Bristol-Myers Squibb
Phase 2/3
230
Kitakyushu-shi, Sapporo, Amagasaki, Sagamihara, Sendai, Shinagawa-ku, Osaka
2022-12-14
Recruiting
AstraZeneca
Phase 2
454
Chūōku, Kashiwa, Kōtoku, Nagoya, Shinagawa-ku, Suita-shi
2022-09-06
Active, closed
Celgene
Phase 3
939
Matsuyama, Higashi-Ibaraki-gun, Shimotsuga, Nerima-ku, Shinagawa-ku, Chuo-shi, Aomori, Chiba
2022-06-23
Active, closed
Regeneron Pharmaceuticals
Observational
717
Yoshida-gun, Fujisawa, Nagaoka, Habikino, Meguro-Ku, Shinagawa-Ku, Kyoto
2021-08-12
Active, closed
AstraZeneca
Phase 3
506
Isehara, Kawasaki-shi, Sapporo, Shinagawa-ku, Yokohama
2021-06-22
Recruiting
Taiho Pharmaceutical Co., Ltd.
Phase 1
59
Bunkyō City, Fukushima, Iruma, Kyoto, Nagasaki, Osaka, Sakai, Shinagawa-Ku
2020-10-30
Active, closed
First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)
NCT03401385Hormone Receptor Positive Breast Cancer, Triple Negative Breast Cancer, Non-small Cell Lung Cancer
Daiichi Sankyo Co., Ltd.
Phase 1
890
Nagoya, Koto-Ku, Shinagawa-Ku, Chūōku, Kashiwa
2018-01-31
Rows per page Showing 1–19 of 19
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-japan/city/shinagawa-ku

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,517 studies in total at the last sync on 15 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 19 of those studies with a site in Shinagawa-Ku.

How many clinical trials are recruiting in Shinagawa-Ku?

9 of the 19 studies on this page are recruiting new participants as of the 15 Nov 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 9 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Shinagawa-Ku), 19 studies
PhaseStudiesRecruitingShare
Phase 35126.3%
Phase 24321.1%
Not applicable3115.8%
Phase 13215.8%
Phase 1/22210.5%
Observational105.3%
Phase 2/3105.3%

Most active sponsors

Lead sponsors with the most studies (Shinagawa-Ku)
Lead sponsorStudiesRecruiting
AstraZeneca32
Bloomage Biotechnology Corp., Ltd.10
Bristol-Myers Squibb10
Celgene10
Daiichi Sankyo11
Daiichi Sankyo Co., Ltd.10
Eli Lilly and Company11
Heartseed Inc.11
Indena S.p.A11
Luye Pharma Group Ltd.10
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.